Phase 2 trial launches for combination stem-cell treatment for ischemic HF – Healio
Phase 2 trial launches for combination stem-cell treatment for ischemic HFHealioThe phase 2, randomized, blinded, placebo-controlled CONCERT trial will study a combination of autologous bone marrow derived mesenchymal cells and endomyocardial biopsy de… Continue reading
